CNBC's Bertha Coombs reports the latest on how Cigna is suing Anthem and expanding its buyback program to a total of $3.7 billion.
CNBC's Bertha Coombs reports the latest on Anthem responding by saying Cigna does not have the right to terminate the deal.
CNBC's Bertha Coombs reports the latest on Aetna and Humana ending their merger agreement after a court sided with the Justice Department objections to the combination.
Anthem will appeal a federal court ruling rejecting its $54 billion merger with Cigna and asked for an expedited hearing to make its case.
Is the end near for the Anthem-Cigna deal? CNBC's Bertha Coombs reports on where the deal currently stands.
A federal judge blocked Anthem's proposed $54-billion acquisition of its smaller rival Cigna.
Coca-Cola, Twitter, Anthem, and Cigna stocks are making headlines on Walll Street.
A federal judge ruled against U.S. health insurer Anthem's proposed $54 billion merger with smaller rival Cigna.
The ruling marks another victory for anti-trust officials, who sued the companies in July last year to stop the deal.
Stocks closed mostly flat as investors looked ahead to Friday's jobs report, amid growing tensions between the US and other global powers.
Some of the names on the move ahead of the open.
U.S. equities closed mostly higher on Wednesday after the Federal Reserve kept interest rates unchanged, as was widely expected.
U.S. equities traded mixed as investors continued to evaluate the latest policies from the White House.
The No. 3 U.S. health insurer's total revenue rose about 5 percent to $15.73 billion but was below expectations.
The risk for companies is that employees, shareholders and customers could punish them more for their silence, Politico's Ben White says.
Stocks notched their worst day of 2017, as a new measure taken by the Trump administration on immigration sent jitters through the market.
With hopes for megamergers dashed and Obamacare-fueled growth in question, investors need answers from health insurers.
Markets will be busy with economic reports and earnings, but Washington could continue to dominate.
Health insurance giant Cigna is dropping coverage for name brand $600 EpiPens, just as CVS nearly halves the price of a rival product. NBC News reports.
Jim Cramer explained why Donald Trump has never really been a stock market guy.